AFVZX
Price
$23.47
Change
+$0.20 (+0.86%)
Updated
Sep 4 closing price
Net Assets
662.51M
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

AFVZX vs VIVIX

Header iconAFVZX vs VIVIX Comparison
Open Charts AFVZX vs VIVIXBanner chart's image
Applied Finance Select Institutional
Price$23.47
Change+$0.20 (+0.86%)
VolumeN/A
Net Assets662.51M
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
AFVZX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AFVZX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFVZX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. AFVZX (663M). VIVIX pays higher dividends than AFVZX: VIVIX (2.11) vs AFVZX (1.04). AFVZX was incepted earlier than VIVIX: AFVZX (9 years) vs VIVIX (27 years). AFVZX (1.13) is less costly to investors than VIVIX (0.04). AFVZX is a more actively managed with annual turnover of: 27.63 vs. VIVIX (9.00). AFVZX has a lower initial minimum investment than VIVIX: AFVZX (10000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. AFVZX (7.24). AFVZX (73.14) and VIVIX (70.16) have equivalent 5 years return.
AFVZXVIVIXAFVZX / VIVIX
Total Expense Ratio0.750.041,875%
Annual Report Gross Expense Ratio1.130.042,825%
Fund Existence9 years27 years-
Gain YTD9.3497.866119%
Front LoadN/AN/A-
Min. Initial Investment1000050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets663M203B0%
Annual Yield % from dividends1.042.1149%
Returns for 1 year7.247.7494%
Returns for 3 years38.5936.61105%
Returns for 5 years73.1470.16104%
Returns for 10 yearsN/A131.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia